Theralase Technologies Inc (TLT.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,692 | 4,977 | 5,899 | 6,688 | 7,880 |
| Receivables | 300 | 237 | 214 | 573 | 485 |
| Inventories | 566 | 660 | 625 | 574 | 452 |
| Other current assets | 440 | 275 | 425 | 198 | 98 |
| TOTAL | $4,998 | $6,150 | $7,163 | $8,033 | $8,916 |
| Non-Current Assets | |||||
| PPE Net | 866 | 953 | 979 | 1,029 | 1,041 |
| Other Non-Current Assets | 81 | 24 | 41 | 53 | 64 |
| TOTAL | $947 | $978 | $1,020 | $1,082 | $1,105 |
| Total Assets | $5,945 | $7,127 | $8,183 | $9,115 | $10,021 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 496 | 421 | 400 | N/A | 408 |
| Accrued Expenses | 343 | 351 | 397 | N/A | 357 |
| TOTAL | $875 | $822 | $856 | $736 | $821 |
| Non-Current Liabilities | |||||
| TOTAL | $0 | $0 | $6 | $21 | $36 |
| Total Liabilities | $875 | $822 | $862 | $757 | $857 |
| Shareholders' Equity | |||||
| Common Shares | 42,120 | 42,120 | 42,120 | 42,120 | 42,120 |
| Retained earnings | -53,092 | -51,811 | -50,744 | -49,600 | -48,506 |
| Other shareholders' equity | 5,098 | 5,469 | 5,469 | 5,469 | 5,295 |
| TOTAL | $5,070 | $6,305 | $7,321 | $8,358 | $9,164 |
| Total Liabilities And Equity | $5,945 | $7,127 | $8,183 | $9,115 | $10,021 |